AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LABECKI, T. D.
Right arrow Articles by THOMPSON, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LABECKI, T. D.
Right arrow Articles by THOMPSON, C. C.
Agricola
Right arrow Articles by LABECKI, T. D.
Right arrow Articles by THOMPSON, C. C.

American Journal of Clinical Nutrition, Vol 3, 141-147, Copyright © 1955 by The American Society for Clinical Nutrition, Inc.

Effect of a Therapeutic Regime on Hyperchylomicronemia and Hypercholesterolemia

THADDEUS D. LABECKI M.D.1, I. B. BRIGHT M.D.1, W. W. LAKE M.D.1, and C. C. THOMPSON M.D.1

1 From the Heart Disease Control Unit, Mississippi State Board of Health

Lipotropic substances—choline, methionine, and inositol in a balanced formula (Methischol)—were administered to 11 patients with proved past myocardial infarction for not less than nine weeks and to 24 elderly women for nine weeks, and to 12 for twelve weeks, the latter group having no history of myocardial infarction.

After nine or more weeks of administration of the lipotropic mixture to the myocardial infarction group, there was a decrease of borderline statistical significance in the total serum cholesterol levels. No such variation was observed in the control group even after prolonged therapy; neither was there any appreciable variation following the administration of a lactose placebo in capsules of identical appearance.

There was a statistically highly significant depression of chylomicron levels (per cent of microscopically visible lipoprotein particles 0.3 micron in diameter and larger) in all subjects on the above regime. Intermittent discontinuation and repeated administration of these substances in four atherosclerotic subjects, followed from five to twelve months, resulted alternately in elevation and depression of chylomicron levels, respectively. Placebo administration did not result in a change in chylomicron levels beyond the statistically expected and experimentally confirmed variation.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
B. I. Chazan
Intravascular Red Cell Aggregation and the Chylomicron Count in Diabetes
Angiology, August 1, 1963; 14(8): 426 - 429.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1955 by The American Society for Nutrition